Literature DB >> 18439697

Dosimetric evaluation of prostate rotations and their correction by couch rotations.

Yvonne R J van Herten1, Jeroen B van de Kamer, Niek van Wieringen, Bradley R Pieters, Arjan Bel.   

Abstract

PURPOSE: To investigate the dosimetric effect of prostate rotations and limited on-line corrections by couch rotations (<or=3 degrees ) for prostate, seminal vesicles and organs at risk.
METHODS: For 5 patients IMRT plans were made, treating the prostate plus base of the seminal vesicles. Realistic and idealised dose distributions were considered, the latter demonstrating extreme effects for rotations and their corrections. Translation errors were assumed to be corrected on-line. For each patient 20 treatments with different rotation errors were simulated: 20 systematic errors were generated and 20 times 35 random deviations were superimposed to simulate day-to-day variations. Using a research module of PLATO-RTS treatments with rotation errors, with and without on-line corrections, were simulated.
RESULTS: The largest dosimetric effect of rotation errors and corrections was found for the seminal vesicles with idealised dose distribution: coverage improved from 92.6% (range 89.9-96.0%) to 95.9% (94.7-98.1%). The gain for the idealised prostate was less: 95.9% (94.4-97.0%) to 97.5% (95.5-98.4%). For the femoral heads the dose increase could be as large as 12.2% (6.2-19.3%).
CONCLUSIONS: On-line correction of rotations can improve target coverage slightly. For organs at risk at a large distance from the isocentre the result can be a significant increase in dose.

Entities:  

Mesh:

Year:  2008        PMID: 18439697     DOI: 10.1016/j.radonc.2008.03.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Dosimetric consequences of rotational errors in radiation therapy of pediatric brain tumor patients.

Authors:  Chris Beltran; Alexander Pegram; Thomas E Merchant
Journal:  Radiother Oncol       Date:  2011-07-02       Impact factor: 6.280

2.  The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapy.

Authors:  Hanan Amro; Daniel A Hamstra; Daniel L Mcshan; Howard Sandler; Karen Vineberg; Scott Hadley; Dale Litzenberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-02       Impact factor: 7.038

3.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

4.  Prostate intrafraction translation margins for real-time monitoring and correction strategies.

Authors:  Dale W Litzenberg; James M Balter; Scott W Hadley; Daniel A Hamstra; Twyla R Willoughby; Patrick A Kupelian; Toufik Djemil; Arul Mahadevan; Shirish Jani; Geoffrey Weinstein; Timothy Solberg; Charles Enke; Lisa Levine; Howard M Sandler
Journal:  Prostate Cancer       Date:  2011-07-13

5.  Prostate rotation detected from implanted markers can affect dose coverage and cannot be simply dismissed.

Authors:  Qingyang Shang; Lawrence J Sheplan Olsen; Kevin Stephans; Rahul Tendulkar; Ping Xia
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

Review 6.  Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: rototranslational shift and dosimetric consequences.

Authors:  Silvia Chiesa; Lorenzo Placidi; Luigi Azario; Gian Carlo Mattiucci; Francesca Greco; Andrea Damiani; Giovanna Mantini; Vincenzo Frascino; Angelo Piermattei; Vincenzo Valentini; Mario Balducci
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

7.  The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer.

Authors:  Dominique C van Rooijen; Jeroen B van de Kamer; René Pool; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel
Journal:  Radiat Oncol       Date:  2009-09-24       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.